Safety and QoL of Trastuzumab With Lapatinib or Chemiotherapy in MBC and HER2+ Patients Refractory to Anti HER2 Therapies
Clinical trial NCT02238509 · UNKNOWN
Trial details
- NCT number
- NCT02238509
- Sponsor
- Consorzio Oncotech
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-01
- Primary completion
- 2017-10-01
- Enrollment
- 154
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.